Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omega-3-acid ethyl esters 90 in severe hypertriglyceridemia
CTR20150739Phase 3Completed
- Sponsor
- Hengrui Therapeutics
- Start
- Dec 2015
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 3 trial of omega-3-acid triglycerides in hypertriglyceridemia, sponsored by Hengrui Therapeutics. Started Dec 2015; status: completed.
02
Drugs
omega-3-acid triglycerides
03
Conditions
hypertriglyceridemia
Beyond the preview
Go deeper on CTR20150739.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150739.